Osteal Therapeutics, Inc. is a biopharmaceutical company based in Texas. Its lobbying filings show it spends on federal government relations related to medical and disease research and clinical labs. The company has reported about $60,000 across four filings and uses McGuireWoods Consulting for lobbying. These filings are current through January 12, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
The latest disclosures for this client.
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Q2MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CLAYTON T. COX
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
MIMI BAIR
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
SCOTT BINKLEY
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
JEREMY GREEN
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
ms STEPHANIE A KENNAN
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Q4MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Q3MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Q2MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
RR